2don MSN
We recently compiled a list of the 10 Stocks With At Least $10 Million In Insider Sales Recently. In this article, we are ...
A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...
3d
MarketBeat on MSNEli Lilly Pours $27B Into U.S. Growth-What It Means for InvestorsWhatever you think of Donald Trump’s tariff policies, one fact stands out: companies are looking to invest more in the United ...
A U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to keep making copies of Eli ...
3d
Health on MSNZepbound Is Now Available in Additional Doses at Lower CostsEli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...
6d
Zacks.com on MSNLilly's Jaypirca Gets CHMP Nod for 2nd Leukemia Indication in EuropeThe CHMP gives a positive opinion to Eli Lilly's Jaypirca in patients with relapsed or refractory CLL in a post-BTK inhibitor setting.
With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.
The reductions come at a time of significant growth overall for Lilly. and soon after the announcement of plans to build new ...
Investing.com -- A United States federal judge has ruled against an injunction that would have permitted compounding ...
Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results